Safety aspects of protease inhibitors for chronic hepatitis C: adverse events and drug-to-drug interactions
نویسندگان
چکیده
منابع مشابه
Toxicity and risks from drug-to-drug interactions of new antivirals for chronic hepatitis C.
The new direct acting antivirals (DAAs), defined as those drugs that are effective in combinations without interferon, have totally changed HCV treatment and probably in few years will also totally change global landscape of advanced liver diseases. The advantage of DAAs is a low-risk/high-benefit ratio. Although overall adverse events during DAAs treatment are limited in frequency and severity...
متن کاملChoosing appropriate theories for understanding hospital reporting of adverse drug events, a theoretical domains framework approach
Adverse drug events (ADEs) may cause serious injuries including death. Spontaneous reporting of ADEs plays a great role in detection and prevention of them, however, underreporting always exists. Although several interventions have been utilized to solve this problem, they are mainly based on experience and the rationale for choosing them has no theoretical base. The vast variety of behavioral ...
متن کاملProtease inhibitors in hepatitis C: from chronic disease to cure.
The recent publication of two controlled trials on boceprevir and three on telaprevir heralds a new era for hepatitis C therapy 1-6 . Bocreprevir and telaprevir are protease inhibitors which act directly on the hepatitis C virus to inhibit replication and are referred to as direct acting antiviral agents (DAAâs). They are the first 2 such agents to be licensed but it is hoped that many more w...
متن کاملPatient Safety: Detection and Prevention of Adverse Drug Events
Adverse Drug Events (ADE) represent a key problem in Public Health. The detection and prevention of ADE is a real challenge for hospitals and healthcare professionals. Healthcare Information and Communication Technologies can contribute to reduce the incidence of preventable ADE. During this workshop, we will discuss the various aspects of detection of ADE through methods like data and semantic...
متن کاملCommon Drug Interactions Leading to Adverse Drug Events in the ICU: Management and Pharmacokinetic Considerations
Critically ill patients, given the nature and extent of their critical illness, frequently receive complex multidrug regimens. Organ dysfunction and polypharmacy potentially can lead to adverse drug interplay and an adverse event. Drug interactions may be pharmacokinetic or pharmacodynamic. A pharmacokinetic interaction arises when one drug alters the absorption, distribution, metabolism, or el...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Brazilian Journal of Infectious Diseases
سال: 2013
ISSN: 1413-8670
DOI: 10.1016/j.bjid.2012.10.010